These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15108017)

  • 41. [Value of contrast-enhanced ultrasound in the diagnosis of hepatocarcinoma in focal lesions detected in patients with liver disease].
    Gómez Rodríguez RA; Artaza Varasa T; González de Frutos C; Sánchez Ruano JJ; Repiso Ortega A; Pérez-Grueso Macías MJ; Muñoz Rosas C; Carrobles Jiménez JM
    Gastroenterol Hepatol; 2007; 30(7):381-6. PubMed ID: 17692194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparative diagnostic value of computed tomography and contrast-enhanced ultrasonography in diagnosis of focal liver lesions].
    Zviniene K; Zaboriene I; Basevicius A; Pundzius J
    Medicina (Kaunas); 2009; 45(10):751-63. PubMed ID: 19996661
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liver.
    von Herbay A; Vogt C; Häussinger D
    AJR Am J Roentgenol; 2002 Nov; 179(5):1273-9. PubMed ID: 12388513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
    Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
    Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.
    Roux M; Pigneur F; Calderaro J; Baranes L; Chiaradia M; Tselikas L; Decaens T; Costentin C; Laurent A; Azoulay D; Mallat A; Zafrani ES; Rahmouni A; Luciani A
    J Magn Reson Imaging; 2015 Nov; 42(5):1249-58. PubMed ID: 25851028
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of contrast-enhanced sonography of focal liver lesions before percutaneous biopsy.
    Wu W; Chen MH; Yin SS; Yan K; Fan ZH; Yang W; Dai Y; Huo L; Li JY
    AJR Am J Roentgenol; 2006 Sep; 187(3):752-61. PubMed ID: 16928941
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Focal liver lesions: clinical usefulness of contrast-enhanced ultrasound in the selection of surgical patients].
    Bartolotta TV; Sandonato L; Taibbi A; Latteri S; Soresi M; Lombardo G; Genova C; Latteri MA
    Chir Ital; 2009; 61(3):295-307. PubMed ID: 19694231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contrast media-enhanced power Doppler sonography for evaluation of hemangiomas and malignant tumors in the liver.
    Karabacakoglu A; Karakose S; Cil AS; Kaya A
    J Gastroenterol Hepatol; 2003 Jan; 18(1):92-8. PubMed ID: 12519230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients.
    von Herbay A; Westendorff J; Gregor M
    J Clin Ultrasound; 2010 Jan; 38(1):1-9. PubMed ID: 19790253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differentiation of focal liver lesions: usefulness of parametric imaging with contrast-enhanced US.
    Anaye A; Perrenoud G; Rognin N; Arditi M; Mercier L; Frinking P; Ruffieux C; Peetrons P; Meuli R; Meuwly JY
    Radiology; 2011 Oct; 261(1):300-10. PubMed ID: 21746815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
    Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
    Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Classification of hypervascular liver lesions based on hepatic artery and portal vein blood supply coefficients calculated from triphasic CT scans.
    Boas FE; Kamaya A; Do B; Desser TS; Beaulieu CF; Vasanawala SS; Hwang GL; Sze DY
    J Digit Imaging; 2015 Apr; 28(2):213-23. PubMed ID: 25183580
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pulse inversion sonography in the early phase of the sonographic contrast agent Levovist: differentiation between benign and malignant focal liver lesions.
    von Herbay A; Vogt C; Häussinger D
    J Ultrasound Med; 2002 Nov; 21(11):1191-200. PubMed ID: 12418760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results.
    Jung EM; Schreyer AG; Schacherer D; Menzel C; Farkas S; Loss M; Feuerbach S; Zorger N; Fellner C
    Clin Hemorheol Microcirc; 2009; 43(1-2):57-69. PubMed ID: 19713601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Three-dimensional contrast-enhanced sonography of vascular patterns of focal liver tumors: pilot study of visualization methods.
    Luo W; Numata K; Morimoto M; Nozaki A; Nagano Y; Sugimori K; Tanaka K
    AJR Am J Roentgenol; 2009 Jan; 192(1):165-73. PubMed ID: 19098197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US.
    Isozaki T; Numata K; Kiba T; Hara K; Morimoto M; Sakaguchi T; Sekihara H; Kubota T; Shimada H; Morizane T; Tanaka K
    Radiology; 2003 Dec; 229(3):798-805. PubMed ID: 14563903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The usefulness of 1.5 harmonic imaging ultrasonography with Levovist in the diagnosis of focal hepatic tumors.
    Yamamoto K; Shiraki K; Nakanishi S; Fuke H; Hashimoto A; Shimizu A; Nakano T
    Int J Oncol; 2005 Oct; 27(4):989-95. PubMed ID: 16142315
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of hypervascular hepatocellular carcinoma by dynamic magnetic resonance imaging with double-echo chemical shift in-phase and opposed-phase gradient echo technique: comparison with dynamic helical computed tomography imaging with double arterial phase.
    Noguchi Y; Murakami T; Kim T; Hori M; Osuga K; Kawata S; Okada A; Sugiura T; Tomoda K; Narumi Y; Nakamura H
    J Comput Assist Tomogr; 2002; 26(6):981-7. PubMed ID: 12488747
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients.
    Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A
    Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.